Filana Therapeutics (MEX:FLNA) Common Stock: MXN0.87 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FLNA Filana Therapeutics Inc MEX:FLNA
34 GF Score
Price MXN23.00
! 2 Warning Signs
View Full Analysis

What is Filana Therapeutics Common Stock?

Filana Therapeutics MEX:FLNA 34 Common Stock is MXN0.87 Mil as of Mar. 2026. GuruFocus rates MEX:FLNA with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Filana Therapeutics's quarterly common stock declined from Sep. 2025 (MXN0.88 Mil) to Dec. 2025 (MXN0.86 Mil) but then increased from Dec. 2025 (MXN0.86 Mil) to Mar. 2026 (MXN0.87 Mil).

Filana Therapeutics's annual common stock increased from Dec. 2023 (MXN0.71 Mil) to Dec. 2024 (MXN1.00 Mil) but then declined from Dec. 2024 (MXN1.00 Mil) to Dec. 2025 (MXN0.86 Mil).

Filana Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Filana Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Filana Therapeutics Common Stock Chart

Filana Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.82 0.71 1.00 0.86

Filana Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 0.90 0.88 0.86 0.87
MEX:FLNA
34GF Score
Filana Therapeutics Inc MEX:FLNA
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Filana Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of MXN0.87 Mil mean?
Filana Therapeutics (MEX:FLNA) has a Common Stock of MXN0.87 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Filana Therapeutics and its competitors.
Is Filana Therapeutics' Common Stock too high?
Filana Therapeutics' current Common Stock is MXN0.87 Mil. Overall, Filana Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Filana Therapeutics' Common Stock compare to BOLD and INKT?
Filana Therapeutics' Common Stock of MXN0.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Filana Therapeutics and its competitors. Filana Therapeutics's current Common Stock is MXN0.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Filana Therapeutics stock overvalued right now?
Filana Therapeutics (MEX:FLNA) has a current Common Stock of MXN0.87 Mil. The current Common Stock is MXN0.87 Mil. Filana Therapeutics' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Filana Therapeutics (MEX:FLNA), the current Common Stock is MXN0.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Filana Therapeutics Business Description

Other Exchanges FLNA:USAPX91:Germany
Address 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
34GF Score

Get the complete analysis for MEX:FLNA

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN23.00
Price